Clinical Trial Update: Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study

View source ↗

Summary

An ongoing real-world study evaluating a Trop-2–targeting antibody-drug conjugate in breast cancer patients with brain metastases, sponsored by Peking Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases From Breast Cancer
• Breast Cancer

Drugs mentioned

• Trop-2 ADC (Trop-2-targeting antibody-drug conjugate)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Breast Cancer, Brain Metastases From Breast Cancer | Status: RECRUITING